Commave Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for COMMAVE THERAP, and when can generic versions of COMMAVE THERAP drugs launch?
COMMAVE THERAP has one approved drug.
There are six US patents protecting COMMAVE THERAP drugs.
There are sixty-six patent family members on COMMAVE THERAP drugs in twenty-eight countries.
Drugs and US Patents for Commave Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Commave Therap | AZSTARYS | dexmethylphenidate hydrochloride; serdexmethylphenidate chloride | CAPSULE;ORAL | 212994-002 | May 7, 2021 | RX | Yes | No | 10,954,213 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Commave Therap | AZSTARYS | dexmethylphenidate hydrochloride; serdexmethylphenidate chloride | CAPSULE;ORAL | 212994-001 | May 7, 2021 | RX | Yes | No | 9,079,928 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Commave Therap | AZSTARYS | dexmethylphenidate hydrochloride; serdexmethylphenidate chloride | CAPSULE;ORAL | 212994-002 | May 7, 2021 | RX | Yes | No | 10,759,778 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Commave Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112019011640 | ⤷ Try a Trial |
Croatia | P20170555 | ⤷ Try a Trial |
Japan | 6505822 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.